Slechtste belegger ooit schreef op 15 januari 2019 21:54:
[...]
Voor degene die zoekt naar Gala:
Gilead Vs. AbbVie In Government Shutdown
Theoretically, it will also be challenging for Gilead Sciences (GILD) to schedule a meeting with the FDA to discuss an ulcerative colitis drug. Gilead, partnering with Galapagos (GLPG), is studying the testicular safety of the drug, filgotinib, in men with ulcerative colitis.
Meanwhile, AbbVie (ABBV) appears to have filed its application for approval of a rival drug ahead of the government shutdown, on Dec. 20.